Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GHNASDAQ:OPCHNYSE:PACSNASDAQ:RDNT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$43.10+1.1%$42.40$15.81▼$50.89$5.32B1.52.13 million shs3.25 million shsOPCHOption Care Health$32.89-1.6%$30.44$21.39▼$34.85$5.44B1.331.61 million shs2.60 million shsPACSPACS Group$12.13-1.7%$13.54$12.04▼$43.92$1.85BN/A532,932 shs473,295 shsRDNTRadNet$47.24-4.1%$61.99$42.45▼$93.65$3.50B1.85890,877 shs872,017 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health+1.10%+1.03%-2.93%+23.35%+131.22%OPCHOption Care Health-1.59%-4.94%+4.91%+40.62%+0.46%PACSPACS Group-1.82%-8.54%-14.50%-18.38%+1,212,499,900.00%RDNTRadNet-4.06%-11.02%-24.23%-39.79%+2.65%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGHGuardant Health4.1648 of 5 stars3.52.00.04.42.52.50.6OPCHOption Care Health4.1302 of 5 stars2.45.00.04.23.02.50.6PACSPACS Group3.709 of 5 stars3.43.00.00.01.30.03.1RDNTRadNet4.1619 of 5 stars3.73.00.04.62.02.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.00Buy$48.4012.30% UpsideOPCHOption Care Health 2.75Moderate Buy$33.000.33% UpsidePACSPACS Group 2.88Moderate Buy$34.00180.41% UpsideRDNTRadNet 3.40Buy$76.7562.47% UpsideCurrent Analyst Ratings BreakdownLatest PACS, OPCH, GH, and RDNT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/6/2025GHGuardant HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$42.00 ➝ $52.003/6/2025OPCHOption Care HealthJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$40.00 ➝ $41.003/5/2025RDNTRadNetRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeOutperform ➝ Strong-Buy$85.00 ➝ $65.002/27/2025OPCHOption Care HealthBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$33.00 ➝ $38.002/26/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$34.00 ➝ $50.002/24/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$47.00 ➝ $52.002/24/2025GHGuardant HealthGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$56.00 ➝ $56.002/24/2025GHGuardant HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$42.00 ➝ $60.002/21/2025GHGuardant HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$49.00 ➝ $56.002/21/2025GHGuardant HealthRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$39.00 ➝ $59.002/21/2025GHGuardant HealthJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$50.00 ➝ $55.00(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$739.02M7.20N/AN/A$1.34 per share32.16OPCHOption Care Health$5.00B1.09$1.91 per share17.19$8.03 per share4.10PACSPACS Group$3.56B0.52N/AN/AN/A∞RDNTRadNet$1.83B1.91$2.51 per share18.81$11.79 per share4.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$479.45M-$3.56N/AN/AN/A-59.05%-19,157.20%-25.96%5/8/2025 (Estimated)OPCHOption Care Health$267.09M$1.2227.6426.102.304.37%15.30%6.57%4/22/2025 (Estimated)PACSPACS Group$112.87MN/A0.006.810.49N/AN/AN/AN/ARDNTRadNet$3.04M$0.03N/A89.13N/A-0.25%4.29%1.45%5/14/2025 (Estimated)Latest PACS, OPCH, GH, and RDNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/27/2025Q4 2024RDNTRadNet$0.21$0.22+$0.01$0.07$459.42 million$477.10 million2/20/2025Q4 2024GHGuardant Health-$0.75-$0.90-$0.15-$0.90$192.50 million$201.81 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/APACSPACS GroupN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A6.225.85OPCHOption Care Health0.771.731.32PACSPACS Group0.821.711.71RDNTRadNet0.892.162.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%OPCHOption Care Health98.05%PACSPACS GroupN/ARDNTRadNet77.90%Insider OwnershipCompanyInsider OwnershipGHGuardant Health5.50%OPCHOption Care Health0.64%PACSPACS GroupN/ARDNTRadNet5.12%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health1,779123.42 million116.76 millionNot OptionableOPCHOption Care Health7,802165.32 million169.09 millionOptionablePACSPACS Group32,433152.40 millionN/AOptionableRDNTRadNet8,97074.04 million70.24 millionOptionablePACS, OPCH, GH, and RDNT HeadlinesRecent News About These CompaniesRadNet, Inc. to Present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference March 17th, 2025March 13 at 6:00 AM | globenewswire.comRadNet, Inc. (NASDAQ:RDNT) Director David L. Swartz Sells 25,000 SharesMarch 12 at 10:18 PM | marketbeat.comWhich Is a Better Investment, Alignment Healthcare, Inc. or RadNet, Inc. Stock?March 12 at 12:40 PM | aaii.comDirector Of RadNet Makes $1.27M SaleMarch 12 at 12:40 PM | benzinga.comAGF Management Ltd. Raises Stock Holdings in RadNet, Inc. (NASDAQ:RDNT)March 12 at 5:48 AM | marketbeat.comRadNet, Inc. (NASDAQ:RDNT) Shares Sold by Victory Capital Management Inc.March 12 at 3:33 AM | marketbeat.comThe five-year decline in earnings might be taking its toll on RadNet (NASDAQ:RDNT) shareholders as stock falls 5.5% over the past weekMarch 11 at 6:54 PM | finance.yahoo.comRadNet: On The Sidelines For NowMarch 11 at 6:54 PM | seekingalpha.comRadNet, Inc. (NASDAQ:RDNT) Receives $76.75 Consensus Target Price from BrokeragesMarch 10 at 1:21 AM | americanbankingnews.comGlobal Alpha Capital Management Ltd. Lowers Stake in RadNet, Inc. (NASDAQ:RDNT)March 9, 2025 | marketbeat.comRadNet, Inc. (NASDAQ:RDNT) CEO Sells $50,520.00 in StockMarch 8, 2025 | marketbeat.comInsider Selling: RadNet, Inc. (NASDAQ:RDNT) CEO Sells $105,160.00 in StockMarch 8, 2025 | marketbeat.comRadNet, Inc. (NASDAQ:RDNT) CEO Cornelis Wesdorp Sells 1,000 SharesMarch 8, 2025 | insidertrades.comRadNet, Inc. (NASDAQ:RDNT) Shares Sold by Bank of New York Mellon CorpMarch 8, 2025 | marketbeat.comForecasting The Future: 4 Analyst Projections For RadNetMarch 7, 2025 | benzinga.comRadNet, Inc. (NASDAQ:RDNT) Given Consensus Rating of "Buy" by AnalystsMarch 7, 2025 | marketbeat.comRadNet (NASDAQ:RDNT) Stock Rating Upgraded by Raymond JamesMarch 7, 2025 | americanbankingnews.comAclarion announces expansion plans with RadNet affiliates in NY, NJMarch 6, 2025 | markets.businessinsider.comRadNet (NASDAQ:RDNT) Upgraded by Raymond James to Strong-Buy RatingMarch 6, 2025 | marketbeat.comRadNet upgraded to Strong Buy from Outperform at Raymond JamesMarch 6, 2025 | markets.businessinsider.comRaymond James Upgrades RadNet (RDNT)March 6, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesNVIDIA’s Hidden AI Play: The Truth Behind Its WeRide InvestmentBy Gabriel Osorio-Mazilli | February 14, 2025View NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide InvestmentArcher Aviation Lands BlackRock Investment—What’s Next for ACHR?By Thomas Hughes | February 13, 2025View Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?Biotechs on the Brink: 2 Stocks With Huge PotentialBy Nathan Reiff | February 14, 2025View Biotechs on the Brink: 2 Stocks With Huge Potential3 Reasons Micron Stock Is Deeply Undervalued Right NowBy Thomas Hughes | February 12, 2025View 3 Reasons Micron Stock Is Deeply Undervalued Right NowNebius Group: NVIDIA’s Investment Sparks All-Time Highs By Ryan Hasson | February 19, 2025View Nebius Group: NVIDIA’s Investment Sparks All-Time Highs PACS, OPCH, GH, and RDNT Company DescriptionsGuardant Health NASDAQ:GH$43.10 +0.47 (+1.10%) Closing price 03/12/2025 04:00 PM EasternExtended Trading$43.42 +0.32 (+0.74%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Option Care Health NASDAQ:OPCH$32.89 -0.53 (-1.59%) Closing price 03/12/2025 04:00 PM EasternExtended Trading$32.88 -0.01 (-0.02%) As of 03/12/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.PACS Group NYSE:PACS$12.12 -0.21 (-1.66%) Closing price 03/12/2025 03:58 PM EasternExtended Trading$12.25 +0.13 (+1.03%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.RadNet NASDAQ:RDNT$47.24 -2.00 (-4.06%) Closing price 03/12/2025 04:00 PM EasternExtended Trading$47.08 -0.16 (-0.33%) As of 07:57 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ramaco Resources Pins Hopes on Coal's Untapped Potential Beyond a Market Correction, Moves to Make Now NVIDIA Stock Remains Stunningly Undervalued—Here’s Why Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy 3 Stocks Institutions Are Quietly Dumping Marvell’s 40% Drop Presents a Compelling Buying Opportunity These 3 Dividend Stocks Jumped 15% in a Month—More to Come? Why Wayfair Stock May Be a Hidden Gem for Value Investors Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
